{"id":"https://openalex.org/W2765392011","doi":"https://doi.org/10.1007/s00262-017-2081-0","title":"A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice","display_name":"A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice","alternate_titles":[],"publication_year":2017,"publication_date":"2017-10-24","ids":{"openalex":"https://openalex.org/W2765392011","doi":"https://doi.org/10.1007/s00262-017-2081-0","mag":"2765392011","pmid":"https://pubmed.ncbi.nlm.nih.gov/29067496","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11028296"},"language":"en","primary_location":{"id":"doi:10.1007/s00262-017-2081-0","doi":"https://doi.org/10.1007/s00262-017-2081-0","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00262-017-2081-0","pdf_url":null,"source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2765392011"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11028296/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102821673","display_name":"Timothy S. Fisher","orcid":"https://orcid.org/0000-0002-3682-4103","observed_orcids":["https://orcid.org/0000-0002-3682-4103"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Timothy S. Fisher","raw_affiliation_strings":["Oncology Research and Development Pfizer Inc., La Jolla, CA, USA. timothy.s.fisher@pfizer.com","Oncology Research and Development Pfizer Inc., Pearl River, NY, USA. timothy.s.fisher@pfizer.com","Pfizer Inc., 10777 Science Center Drive, San Diego, CA, 92121, USA. timothy.s.fisher@pfizer.com","Oncology Research and Development Pfizer Inc., La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., La Jolla, CA, USA. timothy.s.fisher@pfizer.com","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., Pearl River, NY, USA. timothy.s.fisher@pfizer.com","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Pfizer Inc., 10777 Science Center Drive, San Diego, CA, 92121, USA. timothy.s.fisher@pfizer.com","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010569095","display_name":"Andrea T. Hooper","orcid":"https://orcid.org/0000-0003-1131-1229","observed_orcids":["https://orcid.org/0000-0003-1131-1229"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea T. Hooper","raw_affiliation_strings":["Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","Oncology Research and Development Pfizer Inc., Pearl River, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., Pearl River, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103353169","display_name":"Justin Lucas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Lucas","raw_affiliation_strings":["Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","Oncology Research and Development Pfizer Inc., Pearl River, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., Pearl River, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109293451","display_name":"Tracey H. Clark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tracey H. Clark","raw_affiliation_strings":["BioMedicine Design Pfizer Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design Pfizer Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065688760","display_name":"Allison K. Rohner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allison K. Rohner","raw_affiliation_strings":["Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","Oncology Research and Development Pfizer Inc., Pearl River, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., Pearl River, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068856435","display_name":"Bryan Peano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bryan Peano","raw_affiliation_strings":["Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","Oncology Research and Development Pfizer Inc., Pearl River, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., Pearl River, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mark W. Elliott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark W. Elliott","raw_affiliation_strings":["Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","Oncology Research and Development Pfizer Inc., Pearl River, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., Pearl River, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000804175","display_name":"Konstantinos E. Tsaparikos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Konstantinos Tsaparikos","raw_affiliation_strings":["Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","Oncology Research and Development Pfizer Inc., Pearl River, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., Pearl River, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hui Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hui Wang","raw_affiliation_strings":["Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","Oncology Research and Development Pfizer Inc., Pearl River, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., Pearl River, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108833427","display_name":"Jonathan Golas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Golas","raw_affiliation_strings":["Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","Oncology Research and Development Pfizer Inc., Pearl River, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., Pearl River, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064656469","display_name":"Maria Gavriil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Gavriil","raw_affiliation_strings":["Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","Oncology Research and Development Pfizer Inc., Pearl River, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., Pearl River, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086102379","display_name":"Nahor Haddish\u2010Berhane","orcid":"https://orcid.org/0009-0008-3071-8255","observed_orcids":["https://orcid.org/0009-0008-3071-8255"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nahor Haddish-Berhane","raw_affiliation_strings":["BioMedicine Design Pfizer Inc., Cambridge, MA, USA","Johnson and Johnson Pharmaceutical Research and Development, Spring House, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design Pfizer Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Johnson and Johnson Pharmaceutical Research and Development, Spring House, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051181862","display_name":"Lioudmila Tchistiakova","orcid":"https://orcid.org/0009-0007-1298-4456","observed_orcids":["https://orcid.org/0009-0007-1298-4456"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lioudmila Tchistiakova","raw_affiliation_strings":["BioMedicine Design Pfizer Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design Pfizer Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052067361","display_name":"Hans\u2010Peter Gerber","orcid":"https://orcid.org/0000-0002-0741-9328","observed_orcids":["https://orcid.org/0000-0002-0741-9328"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hans-Peter Gerber","raw_affiliation_strings":["Maverick Therapeutics, Brisbane, CA, USA","Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","Oncology Research and Development Pfizer Inc., Pearl River, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maverick Therapeutics, Brisbane, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., Pearl River, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103162930","display_name":"Adam R. Root","orcid":"https://orcid.org/0009-0006-5033-078X","observed_orcids":["https://orcid.org/0009-0006-5033-078X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam R. Root","raw_affiliation_strings":["BioMedicine Design Pfizer Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMedicine Design Pfizer Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034713324","display_name":"Chad May","orcid":"https://orcid.org/0000-0002-6516-3754","observed_orcids":["https://orcid.org/0000-0002-6516-3754"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chad May","raw_affiliation_strings":["Maverick Therapeutics, Brisbane, CA, USA","Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","Oncology Research and Development Pfizer Inc., Pearl River, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maverick Therapeutics, Brisbane, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., La Jolla, CA, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Oncology Research and Development Pfizer Inc., Pearl River, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5102821673"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":1.5166,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.80130069,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"67","issue":"2","first_page":"247","last_page":"259"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5605000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5605000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.1565999984741211,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.14000000059604645,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.8109999895095825},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.796999990940094},{"id":"https://openalex.org/keywords/p-cadherin","display_name":"P-cadherin","score":0.9860000014305115},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8560000061988831},{"id":"https://openalex.org/keywords/t-cell-infiltration","display_name":"T cell infiltration","score":0.6389999985694885},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8550000190734863},{"id":"https://openalex.org/keywords/pharmacodynamic-markers","display_name":"pharmacodynamic biomarkers","score":0.6100000143051147},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6718186140060425},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.625006377696991},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5393149852752686},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5107138156890869},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4935868978500366},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.46026545763015747},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.42630597949028015},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.41267552971839905},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3966345191001892},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3581324815750122},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31758666038513184},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06589367985725403},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015820","descriptor_name":"Cadherins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D017252","descriptor_name":"CD3 Complex","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019073","descriptor_name":"HT29 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045325","descriptor_name":"HCT116 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s00262-017-2081-0","doi":"https://doi.org/10.1007/s00262-017-2081-0","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00262-017-2081-0","pdf_url":null,"source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},{"id":"pmid:29067496","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29067496","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunology, immunotherapy : CII","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11028296","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11028296/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunol Immunother","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:11028296","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11028296/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunol Immunother","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320319264","display_name":"MacroGenics","ror":"https://ror.org/01hcd4187"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1524274652","https://openalex.org/W1528364670","https://openalex.org/W1585154103","https://openalex.org/W1767508090","https://openalex.org/W1801106228","https://openalex.org/W2003896199","https://openalex.org/W2004159506","https://openalex.org/W2015270439","https://openalex.org/W2025835234","https://openalex.org/W2040787108","https://openalex.org/W2056362227","https://openalex.org/W2057026778","https://openalex.org/W2059739979","https://openalex.org/W2060819744","https://openalex.org/W2064785663","https://openalex.org/W2086766201","https://openalex.org/W2096420946","https://openalex.org/W2099241614","https://openalex.org/W2111742915","https://openalex.org/W2125221295","https://openalex.org/W2126086339","https://openalex.org/W2131593373","https://openalex.org/W2146867769","https://openalex.org/W2152844095","https://openalex.org/W2154312302","https://openalex.org/W2158876620","https://openalex.org/W2170035372","https://openalex.org/W2291299225","https://openalex.org/W2435830227","https://openalex.org/W2465447594","https://openalex.org/W2534628219","https://openalex.org/W2597151763","https://openalex.org/W2600695631","https://openalex.org/W2748772361","https://openalex.org/W2807432296","https://openalex.org/W2889938040","https://openalex.org/W3001236019"],"related_works":["https://openalex.org/W4224096887","https://openalex.org/W2406367143","https://openalex.org/W2287797869","https://openalex.org/W2291299225","https://openalex.org/W2308402383","https://openalex.org/W4393087043","https://openalex.org/W3210177310","https://openalex.org/W4410363754","https://openalex.org/W2946458441","https://openalex.org/W7082976255"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2765392011","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2017-11-10T00:00:00"}
